Currently, PYCR1 has been reported to regulate tumour cell proliferation in hepatocellular carcinoma and cloud be an effective therapeutic target for multiple myeloma58,59, as well as inhibit the development of clear cell renal cell carcinoma by causing mitochondrial dysfunction and interfering with oxidative stress pathways60. Here, PYCR1 is linked to hepatocellular carcinoma.